Omega-3 Fatty Acids and Cardiovascular Disease
Publisher: Agency for Healthcare Research and Quality 2016
Number of pages: 1252
There have been hundreds of observational studies and clinical trials conducted to evaluate the effect of omega-3 fatty acids (n-3 FA) on CV disease (CVD) and its risk factors and intermediate markers. The n-3 FA are a group of long-chain and very-long-chain polyunsaturated fatty acids (PUFA) that are substrates for the synthesis of eicosanoids and are important components of cell membranes that impact fluidity.
Home page url
Download or read it online for free here:
by Robert M. Anderson - Racquet Press
Written by Robert Anderson, a pioneer cardiac surgeon and inventor of cardiovascular bypass equipment. The website includes a 20 minute video, that presents a clear and intuitive overview of the concepts included in the text.
by W Schuyler Jones, et al. - Agency for Healthcare Research and Quality
This review assessed the comparative effectiveness of antiplatelet therapy, medical therapy, exercise, and endovascular and surgical revascularization in PAD patients with intermittent claudication (IC) or critical limb ischemia (CLI).
- Royal College of Physicians
The guideline covers aspects of diagnosis and the management of atrial fibrillation (AF) in a number of different circumstances. It covers paroxysmal, persistent and permanent AF, and considers AF developing after surgical procedures.
by D. Neil Granger, Elena Senchenkova - Morgan & Claypool Publishers
The microcirculation is highly responsive to the inflammatory response. All segments of the microvasculature exhibit phenotypic changes during inflammation that are directed toward enhancing the delivery of inflammatory cells to the injured tissue.